Amundi Shockwave Medical, Inc. Transaction History

Amundi

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$191.17 - $325.63 $24.7 Million - $42 Million	-129,074 Reduced 29.28%	311,780 $102 Million
Q4 2023 Feb 14, 2024	BUY	$160.99 - $215.69 $51.4 Million - $68.9 Million	319,524 Added 263.35%	440,854 $84 Million
Q3 2023 Nov 14, 2023	BUY	$194.33 - $283.97 $10.8 Million - $15.8 Million	55,678 Added 84.81%	121,330 $24.2 Million
Q2 2023 Aug 14, 2023	BUY	$223.05 - $302.68 $1.36 Million - $1.84 Million	6,080 Added 10.21%	65,652 $18.7 Million
Q1 2023 May 15, 2023	BUY	$175.41 - $217.92 $360,116 - $447,389	2,053 Added 3.57%	59,572 $12.9 Million
Q4 2022 Feb 14, 2023	SELL	$204.38 - $296.82 $491,533 - $713,852	-2,405 Reduced 4.01%	57,519 $11.8 Million
Q3 2022 Nov 14, 2022	SELL	$195.21 - $310.53 $1.6 Million - $2.54 Million	-8,182 Reduced 12.01%	59,924 $17.1 Million
Q2 2022 Aug 15, 2022	BUY	$115.91 - $214.48 $2.17 Million - $4.01 Million	18,713 Added 37.89%	68,106 $13.6 Million
Q1 2022 May 16, 2022	BUY	$127.96 - $207.36 $6.19 Million - $10 Million	48,365 Added 4704.77%	49,393 $10.6 Million
Q4 2021 Feb 14, 2022	BUY	$165.13 - $241.83 $169,753 - $248,601	1,028 New	1,028 $189,000

321K

1.9K

Ticker SWAV
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,927,100
Description
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

Stay updated on Amundi with notifications on news.